Search Results for "Clindamycin Hydrochloride"

16:32 EST 21st January 2017 | BioPortfolio

Matching Channels


Syphilis is a sexually transmitted disease caused by the spirochetal bacteria Treponema pallidum subspecies pallidum. The primary route of transmission of syphilis is through sexual contact however ...

Matching News

FDA Approves Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) Capsules with Abuse-Deterrent Properties for the Management of Pain

Friday, August 19, 2016 -- Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extend...

Transplacental passage of clindamycin from mother to neonate

HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions

Hospira Recalls One Lot of Bupivacaine Hydrochloride Injectables

NewsHospira issues a voluntary nationwide recall for one lot of 0.25% Bupivacaine Hydrochloride Injection, USP due to the presence of particulate matter within a single vial.

Allergan, Adamas announce new Namzaric dosage strengths availability

David Salazar Namzaric is a fixed-dose combination of memantine and 10 mg donepezil hydrochloride indicated to treat moderate to severe Alzheimer’s disease in patients stabilized on 10 mg of do...

Pfizer's abuse-deterrent opioid painkiller wins FDA nod

Pfizer's abuse-deterrent Troxyca ER, or oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules, has b -More- 

Cardiome launches commercial operations in Canada

VANCOUVER, BC – Cardiome Pharma has initiated its commercial sales operations in Canada. The Canadian sales force will immediately begin detailing AGGRASTAT® (tirofiban hydrochloride) to Canadi...

KVK Tech Announces FDA-Approval of Lomaira (phentermine hydrochloride USP) for Weight Reduction

NEWTOWN, Pa., Sept. 20, 2016 /PRNewswire/ -- KVK Tech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Lomaira (phentermine hydrochloride USP) 8 mg tablets CIV, a lo...

Matching PubMed Articles

Evaluation of Different Oral Formulations of Clindamycin Extended Release in Dogs.

The purpose of this study was to evaluate the pharmacokinetics of extended-release formulations (ERFs) of clindamycin with polymeric-based matrices. In a crossover study, 21 healthy adult dogs were ra...

Enhanced efficacy of clindamycin hydrochloride encapsulated in PLA/PLGA based nanoparticle system for oral delivery.

Clindamycin hydrochloride (CLH) is a clinically important oral antibiotic with wide spectrum of antimicrobial activity that includes gram-positive aerobes (staphylococci, streptococci etc.), most anae...

Sequential Parenteral to Oral Clindamycin Dosing in Pediatric Musculoskeletal Infection: A Retrospective Review of 30mg/kg/day vs 40mg/kg/day.

Children with musculoskeletal infection in MRSA prevalent communities are often treated with oral clindamycin. Current guidelines recommend approximately 40 mg/kg/day for MRSA infections. This study...

Transplacental passage of clindamycin from mother to neonate.

To evaluate maternal and neonatal cord blood levels at delivery in patients receiving 900 mg of clindamycin intravenous (IV) every 8 h.

Development of liposome encapsulated clindamycin for treatment of acne vulgaris.

The enhancement of topical delivery of hydrophilic substances by use of multilammelar liposomes was measured ex vivo on pig ear skin and in vivo on hairless mice by electron paramagnetic resonance met...

Search Whole site using Google

Quick Search
Advertisement Advertisement